Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

shutterstock_141299494

Celyad teams-up with Institut Curie to advance its immuno-oncology program

March 22, 2016 Manufacturing and Production, Research and Development Cancer Immunotherapy, Celyad, Institut Curie, cellular immunotherapies

Celyad (Nasdaq: CYAD) on Tuesday said it has partnered with Institut Curie to develop its NKR-T pipeline in cellular immunotherapies …
News
2174264_eisai_logo

Eisai withdraws application for neurodegenerative-disease drug in Japan

March 22, 2016 Manufacturing and Production, Research and Development Eisai, mecobalamin, neurodegenerative disease

Pharma major Eisai (TYO: 4523) on Tuesday said the Japanese regulators have stalled the approval of its drug to treat …
News

BioMarin reports mixed Phase III results for genetic disorder trial-drug Pegvaliase

March 22, 2016 Manufacturing and Production, Research and Development

Biotech firm BioMarin Pharmaceutical (Nasdaq: BMRN) reported mixed results for its trial drug to treat genetic disorder phenylketonuria. Trial drug, …
News
cancer_cells

Darzalex to be trialled in combination with atezolizumab in multiple myeloma and solid tumours

March 22, 2016 Research and Development Genentech, Genmab, Janssen, Roche, atezolizumab, clnical trials, multiple myeloma, phase ib, solid tumours, tumour

Phase Ib clinical studies are set to begin, which will evaluate Darzalex (daratumumab) in combination with atezolizumab in a solid …
News

Raptor’s Procysbi gets Priority Review from Health Canada

March 22, 2016 Manufacturing and Production, Research and Development Canada, Health Canada, Procysbi, Raptor Pharmaceutical, genetic condition

Raptor Pharmaceutical (Nasdaq: RPTP) said Canadian regulators have accepted a priority review for its drug to treat a rare genetic …
News

23andMe’s apps to aid genetic research for Apple’s ResearchKit

March 22, 2016 Manufacturing and Production, Research and Development 23andME, Apple, genetics, research

Privately-held 23andMe has announced a new module for Apple’s (Nasdaq: AAPL) open source ResearchKit software framework that allows scientists to …
News
peter_bains

Sosei appoints Peter Bains as COO and CEO-elect

March 22, 2016 Research and Development

Japan’s Sosei Group has announced the appointment of Syngene chief executive Peter Bains as representative executive officer and chief operating …
Appointment
albumedix

Albumedix technology extends dosing interval in Behring haemophilia B drug

March 22, 2016 Manufacturing and Production, Research and Development Albumedix, GSK, Idelvion, Novozymes, VELTIS, haemophilia B

Novozymes subsidiary Albumedix has scored another big pharma tie-up for its albumin-based half-life extension technology VELTIS, which this time is …
News
disease

FDA approves new anthrax treatment

March 22, 2016 Manufacturing and Production, Research and Development Antibacterial, FDA, US, anthim, anthrax, defense, inhalational

The US Food and Drug Administration (FDA) has approved Anthim (obiltoxaximab) to treat inhalational anthrax in combination with appropriate antibacterial …
News
takeda_research_centre

Takeda presents long-term Entyvio data in CD and UC

March 21, 2016 Manufacturing and Production, Research and Development Crohn's, Crohn's and Colitis, Entyvio, Takeda, ulcerative colitis

Japan’s Takeda has presented interim findings from the GEMINI Long-Term Safety (LTS) study of ulcerative colitis drug Entyvio (vedolizumab) at …
News

ThromboGenics signs €1m licensing deal with Galapagos for diabetic eye disease treatment

March 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

ThromboGenics NV (Euronext Brussels: THR) on Monday said it has signed a €1 million license deal with Galapagos NV (Nasdaq: …
News
christa_wirthumer-hoche

European Medicines Agency elects Christa Wirthumer-Hoche as new chair of management board

March 21, 2016 Medical Communications, Research and Development Christa Wirthumer-Hoche, EMA, European Medicines Agency, chair, chairperson, wirthumer-hoche

Christa Wirthumer-Hoche has been elected chair of the management board of the European Medicine’s Agency. She has served as vice …
Appointment
shutterstock_212432119

Leo Pharma gets EU scientific approval for its psoriasis drug Enstilar

March 21, 2016 Business Services, Research and Development, Sales and Marketing EU, Enstilar, LEO Pharma, psoriasis vulgaris

Leo Pharma on Monday said its drug to treat inflammatory skin condition has received scientific approval in the European Union. …
News
novartissunlight_copy

Novartis’s heart failure drug given final recommendation by NICE

March 21, 2016 Manufacturing and Production, Research and Development Entresto, NICE, Novartis, approval, draft, guidance, heart failure, heart failure drug

The National Institute for Health and Care Excellence (NICE) has issued its final guidance on Entresto (sacubritil/valsartan), a heart failure …
News

TREND: Smallcap biotechs win in stock markets on positive drug trials

March 21, 2016 Research and Development, Sales and Marketing

Troubled Canadian drug firm Valeant Pharma (NYSE: VRX) saw its share price halved in a single day after the company …
Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026